Cerebrospinal fluid-induced retardation of amyloid β aggregation correlates with Alzheimer's disease and the APOE ε4 allele

Por Padayachee, E.R., Zetterberg, H., Portelius, E., Borén, J., Molinuevo, J.L., Andreasen, N., Cukalevski, R., Linse, S., Blennow, K., Andreasson, U.
Publicado no Brain Res (2016)

CSF biomarkers for Alzheimer's pathology and the effect size of APOE ɛ4

Por Andreasson, U, Lautner, R, Schott, J M, Mattsson, N, Hansson, O, Herukka, S-K, Helisalmi, S, Ewers, M, Hampel, H, Wallin, A, Minthon, L, Hardy, J, Blennow, K, Zetterberg, H
Publicado em 2014

A targeted proteomic multiplex CSF assay identifies increased malate dehydrogenase and other neurodegenerative biomarkers in individuals with Alzheimer's disease pathology

Por Paterson, R W, Heywood, W E, Heslegrave, A J, Magdalinou, N K, Andreasson, U, Sirka, E, Bliss, E, Slattery, C F, Toombs, J, Svensson, J, Johansson, P, Fox, N C, Zetterberg, H, Mills, K, Schott, J M
Publicado no Transl Psychiatry (2016)